JAK2 and acquired polycythemia vera: Correction: Efficacy and safety of pegylated interferon in the treatment of JAK2&lt;sup&gt;V617F&lt;/sup&gt;-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study.